Search Results 761-770 of 16797 for CLL
-
Developing nanoparticles as medicine delivery vehicles that can propel chemotherapy medicines to cancer cells. Conducting or leading innovative clinical trials, ...
-
Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region. Acta Haematol. 2024; 147 (3):260-279 Epub 2023 Sept 26
-
90Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases. Blood Lymphat ...
-
Chronic granulomatous disease · Chronic lymphocytic leukemia · Chronic myelogenous leukemia · DiGeorge syndrome (22q11.2 deletion syndrome) · Epidermolysis ...
-
RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, leucovorin calcium, and fluorouracil, work in different ways to stop the growth of tumor cells, ...
-
Regorafenib is a type of drug called a kinase inhibitor. Regorafenib interferes with how some kinase proteins work. Some of these kinases in cancer cells might ...
-
The Copland Cancer Biology and Translational Research Lab at Mayo Clinic creates personalized cancer models and new molecular-targeted therapies to improve ...
-
Closing the care gap for racial disparities in colorectal cancer. Outcomes for patients in a comprehensive screening program from 2000 to 2019.
-
The purpose of this research study is to find out if the experimental treatment, ALLO-715 in combination with ALLO-647, is safe and effective in treating ...
-
... Chronic lymphocytic leukemia, Waldenstrom macroglo...bulinemia, Monoclonal gammopathy of undetermined significance, Plasma cell disorders, AL amyloidosis.